Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
Archives of Internal Medicine|May 26, 2010
Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic useRandall S Stafford, L Kay Bartholomew, William C Cushman, et al.
Stroke|September 29, 2017
Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Tanzila Shams, Alexander P Auchus, Suzanne Oparil, et al.
JAMA Internal Medicine|November 29, 2016
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical TrialRachel Puttnam, Barry R Davis, Sara L Pressel, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Pharmacogenetics and Genomics|May 6, 2009
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT studyAnke-Hilse Maitland-van der Zee, Bas J M Peters, Amy I Lynch, et al.
Frontiers in Pharmacology|October 4, 2014
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT studyAnh N Do, Marguerite R Irvin, Amy I Lynch, et al.
Current Controlled Trials in Cardiovascular Medicine|December 3, 2002
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and ChlorthalidoneLinda B Piller, Barry R Davis, Jeffrey A Cutler, et al.
Circulation|May 3, 2006
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialBarry R Davis, Linda B Piller, Jeffrey A Cutler, et al.
Annals of Internal Medicine|July 29, 2015
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort StudyPaul Muntner, Jeff Whittle, Amy I Lynch, et al.
Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
Archives of Internal Medicine|May 26, 2010
Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic useRandall S Stafford, L Kay Bartholomew, William C Cushman, et al.
Stroke|September 29, 2017
Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)Tanzila Shams, Alexander P Auchus, Suzanne Oparil, et al.
JAMA Internal Medicine|November 29, 2016
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical TrialRachel Puttnam, Barry R Davis, Sara L Pressel, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Pharmacogenetics and Genomics|May 6, 2009
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT studyAnke-Hilse Maitland-van der Zee, Bas J M Peters, Amy I Lynch, et al.
Frontiers in Pharmacology|October 4, 2014
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT studyAnh N Do, Marguerite R Irvin, Amy I Lynch, et al.
Current Controlled Trials in Cardiovascular Medicine|December 3, 2002
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and ChlorthalidoneLinda B Piller, Barry R Davis, Jeffrey A Cutler, et al.
Circulation|May 3, 2006
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialBarry R Davis, Linda B Piller, Jeffrey A Cutler, et al.
Annals of Internal Medicine|July 29, 2015
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort StudyPaul Muntner, Jeff Whittle, Amy I Lynch, et al.
Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.
Pageof 19